A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Alzheimers Disease · Dementia · Alzheimers Disease, Familial

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama in Birmingham, Birmingham, Alabama, United States

    Contact: Principal Investigator (Erik Roberson)
  • University of California San Diego Medical Center, La Jolla, California, United States

    Contact: Principal Investigator (Doug Galasko)
  • Yale University School of Medicine, New Haven, Connecticut, United States

    Contact: Principal Investigator (Christopher Van Dyck)
  • Emory University, Atlanta, Georgia, United States

    Contact: Principal Investigator (James Lah)
  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Principal Investigator (Darren Gitelman)
  • Indiana University School of Medicine, Indianapolis, Indiana, United States

    Contact: Principal Investigator (Jared Brosch)
  • Washington University in St. Louis, St Louis, Missouri, United States

    Contact: Principal Investigator (Barbara Snider)
  • New York University Medical Center, New York, New York, United States

    Contact: Principal Investigator (Thomas Wisniewski, MD)
  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States

    Contact: Principal Investigator (Sarah Berman)
  • Butler Hospital, Providence, Rhode Island, United States

    Contact: Principal Investigator (Edward Denmead Huey)
  • Kerwin Research and Memory Center, Dallas, Texas, United States

    Contact: Principal Investigator (Alka Khera, MD)
  • University of Washington, Seattle, Washington, United States

    Contact: Principal Investigator (Suman Jayadev)
  • Instituto de Investigaciones Neurologicas Raul Carrea, FLENI, Ciudad Autonoma de Buenos Aire, Argentina

    Contact: Principal Investigator (Ricardo Allegri)
  • Neuroscience Research Australia, Randwick, New South Wales, Australia

    Contact: Principal Investigator (Emma Devenney)
  • Alzheimer's Research Australia, Melbourne, Victoria, Australia

    Contact: Principal Investigator (Colin Masters)
  • UBC Hospital, Vancouver, British Columbia, Canada

    Contact: Principal Investigator (Robin Hsiung)
  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

    Contact: Principal Investigator (Mario Masellis)
  • McGill Center for Studies in Aging, Verdun, Quebec, Canada

    Contact: Principal Investigator (Paola Vitali)
  • CHU de Quebec - Hôpital de l' Enfant Jésus, Québec, Canada

    Contact: Principal Investigator (Robert LaForce)
  • Grupo de Neurociencias Sede de la Universidad de Antioquia, Medellín, Colombia

    Contact: Principal Investigator (David Fernando Aguillon Nino, M.D.)
  • CHU de Toulouse - Hôpital Purpan, Toulouse, Haute Garonne, France

    Contact: Principal Investigator (Jérémie Pariente)
  • Hopital Roger Salengro - CHU Lille, Lille, Nord, France

    Contact: Principal Investigator (Adeline Rollin-Sillaire)
  • Groupe Hospitalier Pitie-Salpetriere, Paris, Paris, France

    Contact: Principal Investigator (Nicolas Villian)
  • Hopital Neurologique Pierre Wertheimer, Bron, Rhone, France

    Contact: Principal Investigator (Maité Formaglio)
  • CHU de Rouen - Hôpital Charles Nicolle, Rouen, Seine Maritime, France

    Contact: Principal Investigator (David Wallon)
  • Universitaetsklinikum Tubingen, Tübingen, Baden-Wurttemberg, Germany

    Contact: Principal Investigator (Cristoph Laske, M.D.)
  • LMU-Campus Grosshadern, Munich, Bavaria, Germany

    Contact: Principal Investigator (Johannes Levin, M.D)
  • IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

    Contact: Principal Investigator (Barbara Borroni)
  • Azienda Ospedaliera Universitaria Careggi, Florence, Italy

    Contact: Principal Investigator (Valentina Bessi, M.D.)
  • Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico City, Mexico

    Contact: Principal Investigator (Ana Luisa Sosa Ortiz, M.D.)
  • Brain Research Center, Amsterdam, Netherlands

    Contact: Principal Investigator (Jort Vijverberg, MD)
  • New Zealand Brain Research Institute, Christchurch, New Zealand

    Contact: Principal Investigator (Campbell Le Heron, M.D.)
  • University of Puerto Rico, School of Medicine, San Juan, Puerto Rico

    Contact: Principal Investigator (Ivonne Jimenez-Velazquez)
  • Hospital Clínic I Provincial de Barcelona, Barcelona, Spain

    Contact: Principal Investigator (Raquel Sanchez Valle)
  • The National Hospital for Neurology and Neurosurgery, London, Greater London, United Kingdom

    Contact: Principal Investigator (Catherine Mummery)
Study leads
  • Eric M McDade, DO

    Study Director

    Washington University School of Medicine